VALPROMIDE/CARBAMAZEPINE AND RISK OF TERATOGENICITY-Reference-Cited by-同舟云学术

VALPROMIDE/CARBAMAZEPINE AND RISK OF TERATOGENICITY

Published:1985-02 Issue:8425 Volume:325 Page:397-398
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Pacifici G.M.,Tomson T.,Bertilsson L.,Rane A.

Publisher

Elsevier BV

Subject

General Medicine

Reference10 articles.

1. Possible hazard of valpromide-carbamazepine combination therapy in epilepsy;Meijer;Lancet,1984

2. Single dose kinetics and metabolism of carbamazepine-10, 11-epoxide;Tomson;Clin Pharmacol Ther,1983

3. Carbamazepme metabolism in man: Induction and pharmacogenetic aspects;Eichelbaum;Clin Pharmacokin,1985

4. Epoxide hydrolase and aryl hydrocarbon hydroxylase in human fetal tissues: Activities in nuclear and microsomal fractions and in isolated hepatocytes;Pacifici;Pediatr Pharmacol,1983

5. Influence of carbamazepine-10, 11-oxide on drug metabolizing enzymes;Jung;Biochem Pharmacol,1980

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A PHARMACOKINETICIST'S CRITICISM;Acta Neurologica Scandinavica;2009-01-29

2. Chapter 10 Teratogenicity and Antiepileptic Drugs;International Review of Neurobiology;2008

3. Carbamazepine-Valnoctamide Interaction in Epileptic Patients: In Vitro/In Vivo Correlation;Epilepsia;1993-09

4. Impairment of carbamazepine‐10, 11‐epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjects.;British Journal of Clinical Pharmacology;1992-07

5. Structure–Pharmacokinetic Relationships in a Series of Short Fatty Acid Amides that Possess Anticonvulsant Activity;Journal of Pharmaceutical Sciences;1990-08